Mometasone/Formoterol (dulera) for asthma.
D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D016527:Drug Costs; D004347:Drug Interactions; D004983:Ethanolamines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D000068759:Formoterol Fumarate; D006801:Humans; D036501:Metered Dose Inhalers; D000068656:Mometasone Furoate; D000068758:Mometasone Furoate, Formoterol Fumarate Drug Combination; D011244:Pregnadienediols / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D018927:Anti-Asthmatic Agents; D004338:Drug Combinations; D004983:Ethanolamines; D000068758:Mometasone Furoate, Formoterol Fumarate Drug Combination; D011244:Pregnadienediols; D000068656:Mometasone Furoate; D000068759:Formoterol Fumarate